Dr. Theodore Sy, MD

Dr. Sy practices at Digestive Disease Center - HOPD in Laguna Hills, California.

Dr. Sy's NPI, 1003865627, was assigned on May 9, 2006. Dr. Sy graduated from Feinberg School of Medicine in 2003. Dr. Sy holds California license A90266.

Dr. Sy's primary practice is Digestive Disease Center - HOPD, at 24411 Health Center Dr, Laguna Hills, CA 92653.

Dr. Sy's primary practice is Digestive Disease Center - HOPD in Laguna Hills, California. Dr. Sy is also affiliated with MemorialCare Saddleback Medical Center. The medical group on file is MemorialCare Medical Group. Dmand AI also links Dr. Sy to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sy practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Sy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Sy is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Sy is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, cirrhosis of the liver, colonoscopy, gastroenteritis, hemorrhoids and irritable bowel syndrome (IBS) among the conditions Dr. Sy treats.

CMS data shows 312 Medicare services from Dr. Sy across 10 procedure codes in 2024, for 157 Medicare patients. Medicare paid $26,906 for them.

CMS counts 157 Medicare patients who saw Dr. Sy in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sy's median patient age at 63, with 51% women.

In 2024, Dr. Sy wrote 1,098 Medicare Part D claims for 513 patients. 71% of them were for generic drugs. CMS names the drug for 924 of them, across 18 drugs with 11 or more claims each, at $853,998 in total drug cost. In 2023, CMS named 783 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Sy for performance year 2024, reported as part of a group. Dr. Sy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sy as offering telehealth. CMS counts 30 procedures of colonoscopy by Dr. Sy, more than 54% of the clinicians it reports for that procedure.

Dmand AI links Dr. Sy to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 317 general payments to Dr. Sy from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $2,258.

Dmand AI lists 1 award for Dr. Sy, most recently CMS Stage 1 EHR in 2012.

Dr. Sy graduated from Feinberg School of Medicine in 2003.

Dr. Sy is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.